852
Views
12
CrossRef citations to date
0
Altmetric
Research Paper

C-X-C chemokine receptor 2 correlates with unfavorable prognosis and facilitates malignant cell activities via activating JAK2/STAT3 pathway in non-small cell lung cancer

, , , , , , & show all
Pages 3456-3471 | Received 05 Aug 2019, Accepted 08 Sep 2019, Published online: 15 Nov 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Ying Chen, Meilian Zhao, Dongliang Shen, Qian Yi & Liling Tang. (2022) SNF5 promotes cell proliferation and immune evasion in non-small cell lung cancer. Bioengineered 13:5, pages 11530-11540.
Read now

Articles from other publishers (11)

Saumya Srivastava, Atish Mohanty, Arin Nam, Sharad Singhal & Ravi Salgia. (2022) Chemokines and NSCLC: Emerging role in prognosis, heterogeneity, and therapeutics. Seminars in Cancer Biology 86, pages 233-246.
Crossref
Gunjan Sharma, Ramesh Pothuraju, Ranjana Kumari Kanchan, Surinder Kumar Batra & Jawed Akhtar Siddiqui. (2022) Chemokines network in bone metastasis: Vital regulators of seeding and soiling. Seminars in Cancer Biology 86, pages 457-472.
Crossref
Mariusz Kulinczak, Maria Sromek, Grzegorz Panek, Klara Zakrzewska, Renata Lotocka, Lukasz Michal Szafron, Magdalena Chechlinska & Jan Konrad Siwicki. (2022) Endometrial Cancer-Adjacent Tissues Express Higher Levels of Cancer-Promoting Genes than the Matched Tumors. Genes 13:9, pages 1611.
Crossref
Qijun Yi, Yu’e Miao, Ying Kong, Yan Xu, Jinghao Zhou, Qi Dong & Haiyan Liu. (2022) MiR-579 Inhibits Lung Adenocarcinoma Cell Proliferation and Metastasis via Binding to CRABP2. Computational and Mathematical Methods in Medicine 2022, pages 1-9.
Crossref
D. I. Murashka, A. D. Tahanovich, M. M. Kauhanka, V. I. Prokhorova & O. V. Gotko. (2022) Diagnostic Efficiency of Determining CXCR1, CXCR2 and Hyaluronic Acid in Blood of Patients with Non-Small Cell Lung Cancer. Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry 16:1, pages 45-53.
Crossref
Nannan Zhao, Yanjuan Guo, Ping Liu, Yan Chen & Yan Wang. (2021) Sirtuin 2 promotes cell stemness and MEK/ERK signaling pathway while reduces chemosensitivity in endometrial cancer. Archives of Gynecology and Obstetrics 305:3, pages 693-701.
Crossref
Jan Korbecki, Patrycja Kupnicka, Mikołaj Chlubek, Jarosław Gorący, Izabela Gutowska & Irena Baranowska-Bosiacka. (2022) CXCR2 Receptor: Regulation of Expression, Signal Transduction, and Involvement in Cancer. International Journal of Molecular Sciences 23:4, pages 2168.
Crossref
D.I. Murashka, A.D. Tahanovich, M.M. Kauhanka, V.I. Prokhorova & O.V. Gotko. (2021) Diagnostic efficiency of determining CXCR1, CXCR2 and hyaluronic acid blood level in non-small cell lung cancer patients. Biomeditsinskaya Khimiya 67:5, pages 434-442.
Crossref
Fan Wang, Shuqing Han, Ji Yang, Wenying Yan & Guang Hu. (2021) Knowledge-Guided “Community Network” Analysis Reveals the Functional Modules and Candidate Targets in Non-Small-Cell Lung Cancer. Cells 10:2, pages 402.
Crossref
Lei Wang, Jicheng Tantai & Xiaoli Zhu. (2020) Katanin P60: a potential biomarker for lymph node metastasis and prognosis for non-small cell lung cancer. World Journal of Surgical Oncology 18:1.
Crossref
Chris W D Armstrong, Jonathan A Coulter, Chee Wee Ong, Pamela J Maxwell, Steven Walker, Karl T Butterworth, Oksana Lyubomska, Silvia Berlingeri, Rebecca Gallagher, Joe M O’Sullivan, Suneil Jain, Ian G Mills, Kevin M Prise, Robert G Bristow, Melissa J LaBonte & David J J Waugh. (2020) Clinical and functional characterization of CXCR1/CXCR2 biology in the relapse and radiotherapy resistance of primary PTEN-deficient prostate carcinoma. NAR Cancer 2:3.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.